ARVO 2024: Dr. John Sheppard shares results from GOBI, MOJAVE trials
The 2 FDA registration trials for perfluorohexyloctane resulted in scientifically significant results for improvement of mild and moderate symptoms of dry eye disease.
ARVO 2024: Study shows NutriTears improves signs and symptoms of DED
Neda Gioia, OD, CNS, FOWNS, CFMP, details recent findings on the efficacy of the NutriTears supplement on dry eye symptoms.
CIME 2024: Inder Paul Singh, MD, and the interventional glaucoma mindset
Inder Paul Singh, MD, defines what it means to have an interventional mindset when it comes to glaucoma procedures and treatments during the Controversies in Modern Eye Care 2024 meeting.
CIME 2024: Identifying the constellation of signs and symptoms in TED
Kelsey Roelofs, MD, gives her best methods to identifying and diagnosing thyroid eye disease in her Controversies in Modern Eye Care 2024 presentation.
CIME 2024: Confronting Demodex blepharitis with advanced treatment
Marc Bloomenstein, OD, FAAO, discusses how optometrists can proactively manage Demodex blepharitis by regularly examining eyelids, diagnosing the condition early, and offering treatments to effectively eradicate the mites and prevent future complications.
CIME 2024: The Patient Whisperers cofounders share social media secrets in keynote presentation
May 4th 2024The Patient Whisperers Cofounders Lauren Weaver and Christine Scarlett gave their keynote presentation "The Secret to Crazy Growth: Defining Your Identity on Social Media," at the 2024 Controversies in Modern Eye Care meeting May 4 in Los Angeles, California.
FDA approves iDose TR from Glaukos for reduction of IOP in OAG or ocular hypertension
December 14th 2023iDose TR, a micro-invasive intraocular implant designed to lower IOP in patients with open-angle glaucoma or ocular hypertension, has received FDA approval following a new drug application (NDA) submission.